Hemosiderosis
📧 Sign up to get email alerts when something new happens for Hemosiderosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
A University of Wisconsin–Madison trial evaluating a confounder-corrected quantitative MRI biomarker of hepatic iron content has completed.
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.
A clinical trial protocol assesses whether iron overload influences the incidence of liver complications in long-term survivors (≥10 years) …
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: Safety, Tolerability, and Efficacy of Deferasirox in MDS [Phase 3]
Phase 3 trial evaluating safety, tolerability, and efficacy of deferasirox in myelodysplastic syndromes, focusing on iron chelation in patie…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Efficacy Study in Removing Excess Iron From the Heart [Phase 4]
A Phase 4 clinical trial update reports completion of an efficacy study evaluating removal of excess iron from the heart in patients with th…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Pharmacogenetic Study in Patients Received Iron Chelating Agent
A pharmacogenetic study in patients treated with an iron chelating agent for hemosiderosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-29Clinical Trial Update: Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration) [Phase 4]
This Phase 4 extension study evaluates the efficacy and safety of deferasirox in transfusion-dependent beta-thalassemia patients with iron o…
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients [Phase 2]
Results from an extension Phase 2 study of the iron chelator deferasirox in patients with β-thalassemia and other rare chronic anemias have …